Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.47 |
| ▸ | MGLL | Q99685 | 5/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10767997 | 0.87 | ADRA1A (0.62) | HTR2AADRA1ATAAR1ALOX5PTGS2 | |
| SCHEMBL10601156 | 0.87 | ADRA1A (0.62) | HTR2AADRA1ATAAR1ALOX5PTGS2 | |
| SCHEMBL5133668 | 0.87 | ADRA1A (0.62) | HTR2AADRA1ATAAR1ALOX5PTGS2 | |
| SCHEMBL9889155 | 0.85 | ADRA1A (0.64) | HTR2AADRA1ATAAR1ALOX5PTGS2 | |
| SCHEMBL19854382 | 0.85 | MGLL (0.46) | ALOX5PTGS2MGLL | |
| SCHEMBL15242318 | 0.82 | CCNB2 (0.48) | MGLL | |
| SCHEMBL1081732 | 0.80 | ADRA1A (0.66) | HTR2AADRA1ATAAR1 | |
| SCHEMBL1190110 | 0.80 | HTR2A (0.44) | HTR2ASPHK2ALOX5PTGS2 | |
| SCHEMBL23635375 | 0.79 | ESR2 (0.50) | ALOX5PTGS2MGLL | |
| SCHEMBL13940053 | 0.79 | HTR2A (0.43) | HTR2AADRA1ATAAR1ALOX5PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104903423-B | Monomer, liquid-crystal composition, the manufacture method of liquid crystal display device and liquid crystal display device | 夏普株式会社 | 2018-04-20 | — | — | CN | disclosed |
| US-9719018-B2 | Monomer, liquid crystal composition, liquid crystal display device, and production method for liquid crystal display device | SHARP KABUSHIKI KAISHA (JP) | 2017-08-01 | — | — | US | disclosed |
| US-9719018-B2 | Monomer, liquid crystal composition, liquid crystal display device, and production method for liquid crystal display device | SHARP KABUSHIKI KAISHA (JP) | 2017-08-01 | — | — | US | disclosed |
| CN-104903423-A | Monomer, liquid crystal composition, liquid crystal display device, and production method for liquid crystal display device | SHARP KK | 2015-09-09 | — | — | CN | disclosed |
| US-20150247090-A1 | MONOMER, LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY DEVICE, AND PRODUCTION METHOD FOR LIQUID CRYSTAL DISPLAY DEVICE | SHARP KABUSHIKI KAISHA (JP) | 2015-09-03 | — | — | US | disclosed |
| US-20150247090-A1 | MONOMER, LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY DEVICE, AND PRODUCTION METHOD FOR LIQUID CRYSTAL DISPLAY DEVICE | SHARP KABUSHIKI KAISHA (JP) | 2015-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150247090-A1 | MONOMER, LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY DEVICE, AND PRODUCTION METHOD FOR LIQUID CRYSTAL DISPLAY DEVICE | NLRP1, PYCARD, NLRP3 | HTR2A 1019/4885ADRA1A 4005/4885TAAR1 558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.